Envestnet Asset Management
APYX icon

Envestnet Asset Management’s Apyx Medical APYX Stock Holding History

Envestnet Asset Management’s Portfolio APYX Stock Details APYX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-10,726
Closed -$13.3K – 4304
2024
Q3 		$13.3K Sell
10,726
-1,036
-9% -$1.31K ﹤0.01% 4206
2024
Q2 		$15.8K Sell
11,762
-668
-5% -$985 ﹤0.01% 4145
2024
Q1 		$16.9K Sell
12,430
-5,079
-29% -$10.8K ﹤0.01% 4146
2023
Q4 		$45.9K Buy
17,509
+2,067
+13% +$5K ﹤0.01% 3988
2023
Q3 		$49.4K Buy
15,442
+5,293
+52% +$24.7K ﹤0.01% 3939
2023
Q2 		$51K Sell
10,149
-652
-6% -$3.3K ﹤0.01% 3869
2023
Q1 		$31.1K Sell
10,801
-948
-8% -$2.77K ﹤0.01% 3899
2022
Q4 		$27.5K Buy
11,749
+67
+0.6% +$204 ﹤0.01% 3912
2022
Q3 		$52K Buy
11,682
+239
+2% +$1.71K ﹤0.01% 3804
2022
Q2 		$67K Sell
11,443
-5,499
-32% -$28.2K ﹤0.01% 3792
2022
Q1 		$111K Sell
16,942
-796
-4% -$7.84K ﹤0.01% 3790
2021
Q4 		$227K Buy
17,738
+183
+1% +$2.56K ﹤0.01% 3588
2021
Q3 		$243K Buy
+17,555
New +$185K ﹤0.01% 3408

Other funds holding APYX

NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
ACM
Archon Capital Management Seattle, Washington $246M AUM 130.69% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
HKAM
Horizon Kinetics Asset Management New York $8.82B AUM 23.05% 1-Year Est. Return
SBCM
Silverberg Bernstein Capital Management Armonk, New York $261M AUM 89.93% 1-Year Est. Return
TFCM
Taylor Frigon Capital Management Scottsdale, Arizona $214M AUM 47.29% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Envestnet Asset Management's APYX Position: Q4 2024 in Review

Envestnet Asset Management sold out of Apyx Medical (APYX) in Q4 2024, closing a stake of 10,726 shares — an estimated $13.3K sold.

Envestnet Asset Management first reported a position in APYX in Q3 2021 and held it in 13 quarters. The position peaked at $243K in Q3 2021. 45 funds tracked by Wall St. Rank hold APYX as of Q4 2024.

  • Envestnet Asset Management reported no remaining Apyx Medical position as of Q4 2024 after selling out during the quarter.
  • Envestnet Asset Management sold 10,726 Apyx Medical shares in Q4 2024, an estimated $13.3K.
  • Envestnet Asset Management first reported a position in Apyx Medical in Q3 2021 and held it in 13 quarters.
  • Envestnet Asset Management's Apyx Medical position peaked at $243K in Q3 2021.
  • 45 funds tracked by Wall St. Rank held Apyx Medical as of Q4 2024.

Based on Envestnet Asset Management's 13F filing for Q4 2024, filed 13 Feb 2025.